Belvedere Trading’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q4
Sell
-15,386
Closed -$105K 236
2023
Q3
$105K Sell
15,386
-172
-1% -$1.18K ﹤0.01% 77
2023
Q2
$161K Sell
15,558
-16,623
-52% -$172K ﹤0.01% 82
2023
Q1
$260K Buy
+32,181
New +$260K ﹤0.01% 58
2021
Q2
Sell
-16,473
Closed -$415K 141
2021
Q1
$415K Buy
+16,473
New +$415K 0.03% 64